Two Weeks Until Washington Votes on Killing the 5ng THC Limit — Here’s What Could Still Stop It

A our legislative tracker moving through Olympia would replace the state’s blunt-instrument cannabis DUI threshold with actual impairment testing. The Senate floor vote is April 14. The case for the bill is strong. The obstacles are real.

Washington’s SB 6012 — the bill that would finally retire the state’s 5 nanogram per milliliter THC blood threshold as automatic proof of cannabis DUI — hits the Senate floor in two weeks. It cleared the Law & Justice Committee 7-2 on March 8. The momentum is there. So is the complexity.

This isn’t a sure thing. Here’s the state of play as the April 14 vote approaches, and what the broader West Coast should be watching.

What the Vote Is Actually About

The core issue: Washington’s current per se standard — borrowed from alcohol law in 2012 and never grounded in credible science — treats a 5 ng/mL THC blood reading as legally equivalent to being impaired. It doesn’t matter when you last consumed. It doesn’t matter whether you’re actually impaired. The number triggers the presumption.

SB 6012 repeals that threshold and replaces it with an impairment-based standard: law enforcement must demonstrate actual impairment through standardized field sobriety evaluation and, where applicable, Drug Recognition Expert (DRE) protocol. The blood draw stays in the evidence toolkit; it just loses its status as automatic proof of guilt.

If the bill passes the full legislature and is signed into law, the new standard takes effect January 1, 2027. Every law enforcement agency in the state would be required to complete updated impairment protocol training before that date.

Who This Actually Affects

The people most directly exposed to the current standard aren’t reckless drivers — they’re regular cannabis users, medical patients, and older consumers with slower metabolisms who carry elevated blood THC levels days after their last use.

THC is fat-soluble. It doesn’t clear the bloodstream on any predictable schedule the way alcohol does. A regular user who consumed Friday evening and drives to work Monday morning can test at or above 5 ng/mL while being entirely functional. A medical patient managing chronic pain, PTSD, or epilepsy may maintain blood THC levels above the threshold more or less continuously — not because they’re impaired, but because they’re patients.

Under SB 6012, the relevant question would become: Is this person demonstrably impaired right now? That’s not a weakening of impaired driving law. It’s what impaired driving law should have asked from the start.

What Could Still Kill It (or Slow It Down)

The law enforcement bloc. The Washington State Patrol Association and several county prosecutors have registered opposition, not because they support impaired driving but because the per se standard gives prosecutors clean evidentiary footing in court. A blood number is unambiguous. “Officer observed signs of impairment” opens up challenges. That’s a real concern, and it’s where the House debate will be hardest.

The training cost and timeline. The state fiscal note puts implementation at $4.2 million over two years — retraining law enforcement statewide on updated impairment protocols. With 39 counties and hundreds of municipal departments, that’s not a light lift. Some agencies have never administered DRE protocols at scale. Opponents will argue that the January 2027 effective date is too aggressive; advocates will counter that 14 months is adequate with proper resourcing.

The civil liberties tension. This one cuts in a complicated direction. The per se standard, whatever its scientific failures, gave defendants a clear threshold to contest. A field impairment determination is harder to challenge in court — it’s behavioral, discretionary, and subject to officer interpretation. Defense attorneys in Washington are already flagging this. SB 6012’s sponsors need a better answer to this than they’ve offered publicly.

The racial equity piece. Cannabis DUI enforcement in Washington, like drug enforcement broadly, has not been applied uniformly across racial lines. Moving to an officer-discretion model without robust oversight and accountability mechanisms could trade one structural problem for another. The bill’s sponsors haven’t fully addressed this. It should be a condition of support, not an afterthought.

How the West Coast Compares

Washington is not operating in a vacuum here.

Oregon has never used a per se THC blood limit. DUI enforcement relies on observed impairment and DRE evaluation. Available data has not shown worse impaired driving outcomes compared to states using per se standards — which is the core empirical argument for SB 6012.

California has had an active per se THC limit debate for years without resolution. Repeated legislative proposals have stalled, partly due to law enforcement lobbying and partly due to genuine uncertainty about what an impairment standard would look like at scale.

Alaska and Montana similarly rely on behavioral evidence rather than a THC threshold. Their models are worth studying as Washington designs implementation.

The practical picture: states that have moved away from per se THC limits haven’t seen impaired driving rates spike. The enforcement infrastructure to do this well exists — it just requires investment and commitment. Washington has built more complex cannabis regulatory apparatus than this before.

Key Figures

Primary sponsor: Sen. David Hayashi (D-47th), chair of Senate Law & Justice — introduced the bill with bipartisan co-sponsorship; his committee background gives the bill structural credibility in the chamber.

Committee vote: 7-2, Senate Law & Justice, March 8, 2026. The two dissenting votes reflected law enforcement advocacy concerns about prosecutorial evidentiary standards.

Support: NORML-WA, ACLU of Washington, Washington State Dispensary Association, Association of Criminal Defense Lawyers of Washington.

Opposition: Washington State Patrol Association (training cost concerns, clean evidentiary standard argument); a minority of victims’ advocacy groups favoring retention of per se limits.

What to watch in the House: Floor testimony from county prosecutors and law enforcement associations. If the House Judiciary Committee substantially amends the training mandate or the DRE protocol requirements, the bill’s enforcement architecture gets weaker. Watch whether amendments are technical or substantive.

The Bottom Line

The 5 ng/mL THC blood limit was a 2012 policy convenience that the science never supported. Washington is now close to formally retiring it. The April 14 Senate floor vote, if it goes as the committee vote suggests, is the less contested hurdle — the House is where the real negotiation happens.

This matters beyond Washington. Every West Coast state with a per se THC standard — California, most critically — is watching what happens here. If Washington passes SB 6012 and implements it without a visible enforcement collapse, the domino case for California becomes significantly stronger.

The vote is April 14. CannabisInquirer will have floor vote coverage same day.

Sources: Washington State Legislature (SB 6012 bill page, app.leg.wa.gov); NORML Washington (state law summary); NORML cannabis policy research (March 2026); National Highway Traffic Safety Administration (drug-impaired driving guidance). Previous CI coverage: Washington’s 5 ng/mL THC Limit Was Never About Science — March 27, 2026.

Jo Tanaka covers the West and Pacific beat for CannabisInquirer.com, based in Portland, OR. Former dispensary consultant.